Table 1 Patient characteristics (n = 51)
Characteristic | Median (range) |
|---|---|
Age | 67 (range 52–83) |
Length of clinical follow-up (months) | 23 (range 8–47) |
Time after radiotherapy of the last post-treatment endoscopy (months) | 13 (range 1–35) |
Characteristic | Number (%) |
Ethnicity | Â |
 Caucasian | 30 (59%) |
 African-America | 20 (39%) |
 Other | 1 (2%) |
Pre-SBRT use of anticoagulation therapy | 11 (22%) |
Pre-SBRT hemorrhoids | 4 (8%) |
Radiotherapy | Â |
 SBRT monotherapy | 35 (69%) |
 SBRT boost | 16 (31%) |
Androgen deprivation therapy | Â |
 No | 35 (69%) |
 Yes | 16 (31%) |
NCCN risk category | Â |
 Low | 14 (27%) |
 Intermediate | 28 (55%) |
 High | 9 (18%) |
Gleason score | Â |
 6 | 18 (35%) |
 7 | 24 (47%) |
 8 | 4 (8%) |
 9 | 5 (10%) |
T stage | Â |
 1c | 28 (55%) |
 2a | 10 (20%) |
 2b | 8 (16%) |
 2c | 5 (10%) |
PSA | Â |
 ≤ 10 ng/mL | 41 (80%) |
 > 10 ng/mL | 10 (20%) |